| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (OTCEM:ANEB) through any online brokerage.
There are no as such competitors for ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc.
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc has a consensus price target of $8.00.
The stock price for ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (OTCEM: ANEB) is $0.315 last updated October 9, 2026 at 9:44 AM EDT.
There are no upcoming dividends for ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc.
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc does not have any upcoming earnings scheduled.
There is no upcoming split for ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc.
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
